A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
Public ClinicalTrials.gov record NCT03897257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blinded, Parallel Group Comparison Study of the Safety and Efficacy of UHE-103 in Subjects With Moccasin-Type Tinea Pedis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.
Study identification
- NCT ID
- NCT03897257
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- UHE-103A1 cream Drug
- UHE-103A2 cream Drug
- UHE-103B cream Drug
- UHE-103A1B cream Drug
- UHE-103A2B cream Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2019
- Primary completion
- Oct 20, 2019
- Completion
- May 4, 2020
- Last update posted
- Oct 27, 2021
2019 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 03 | San Diego | California | 92123 | — |
| Site 12 | Melbourne | Florida | 32935 | — |
| Site 06 | Miami | Florida | 33144 | — |
| Site 09 | North Miami Beach | Florida | 33162 | — |
| Site 07 | Rolling Meadows | Illinois | 60008 | — |
| Site 11 | Fridley | Minnesota | 55432 | — |
| Site 04 | Rochester | New York | 14623 | — |
| Site 01 | Austin | Texas | 78759 | — |
| Site 02 | Houston | Texas | 77055 | — |
| Site 10 | San Antonio | Texas | 78229 | — |
| Site 05 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03897257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2021 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03897257 live on ClinicalTrials.gov.